Insulet Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45784P1012
USD
145.76
2.24 (1.56%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
761.70
783.80
706.30
649.10
569.00
597.50
543.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
761.70
783.80
706.30
649.10
569.00
597.50
543.90
Raw Material Cost
223.70
213.50
192.80
192.70
154.80
163.00
162.50
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.70
19.60
15.60
19.60
10.60
8.70
12.30
Selling and Distribution Expenses
312.30
328.60
312.50
255.10
258.20
258.50
231.60
Other Expenses
7.50
7.13
6.16
5.38
4.90
5.19
4.26
Total Expenditure (Excl Depreciation)
625.70
633.00
582.50
521.20
472.60
482.10
449.00
Operating Profit (PBDIT) excl Other Income
136
150.8
123.80000000000001
127.89999999999999
96.4
115.39999999999999
94.9
Other Income
5.60
13.40
12.20
16.80
9.40
10.70
7.10
Operating Profit (PBDIT)
159.90
190.30
157.80
165.70
125.00
146.50
121.10
Interest
14.70
19.60
15.60
19.60
10.60
8.70
12.30
Exceptional Items
0.30
0.10
8.50
-89.80
-39.50
0.00
0.00
Gross Profit (PBDT)
538.00
570.30
513.50
456.40
414.20
434.50
381.40
Depreciation
32.50
30.60
27.90
27.80
26.80
26.50
25.90
Profit Before Tax
113.00
140.20
122.80
28.40
48.10
111.30
82.90
Tax
21.90
38.50
35.20
5.90
12.70
10.60
5.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
91.10
101.60
87.60
22.50
35.40
100.70
77.50
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
91.10
101.60
87.60
22.50
35.40
100.70
77.50
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
91.10
101.60
87.60
22.50
35.40
100.70
77.50
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,302.60
1,515.20
1,384.10
1,462.90
1,330.70
1,211.60
1,118.00
Earnings per share (EPS)
1.3
1.44
1.24
0.32
0.5
1.39
1.08
Diluted Earnings per share
1.3
1.44
1.24
0.32
0.5
1.39
1.08
Operating Profit Margin (Excl OI)
15.99%
18.67%
16.66%
18.66%
15.61%
18.29%
16.2%
Gross Profit Margin
19.1%
21.79%
21.34%
8.66%
13.16%
23.06%
20.0%
PAT Margin
11.96%
12.96%
12.4%
3.47%
6.22%
16.85%
14.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 33.87% vs 28.82% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 157.34% vs -31.26% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 33.48% vs 52.71% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 38.68% vs -64.90% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Insulet Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
761.70
878.38
-116.68
-13.28%
Other Operating Income
0.00
0.00
0.00
Total Operating income
761.70
878.38
-116.68
-13.28%
Raw Material Cost
223.70
262.56
-38.86
-14.80%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
14.70
8.20
6.50
79.27%
Selling and Distribution Expenses
312.30
501.01
-188.71
-37.67%
Other Expenses
7.50
18.33
-10.83
-59.08%
Total Expenditure (Excl Depreciation)
625.70
955.06
-329.36
-34.49%
Operating Profit (PBDIT) excl Other Income
136.00
-76.68
212.68
277.36%
Other Income
5.60
5.71
-0.11
-1.93%
Operating Profit (PBDIT)
159.90
-14.61
174.51
1,194.46%
Interest
14.70
8.20
6.50
79.27%
Exceptional Items
0.30
-5.92
6.22
105.07%
Gross Profit (PBDT)
538.00
615.83
-77.83
-12.64%
Depreciation
32.50
56.35
-23.85
-42.32%
Profit Before Tax
113.00
-85.08
198.08
232.82%
Tax
21.90
0.87
21.03
2,417.24%
Provisions and contingencies
0
0
0.00
Profit After Tax
91.10
-85.95
177.05
205.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
91.10
-85.95
177.05
205.99%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
91.10
-85.95
177.05
205.99%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
1,302.60
2,401.05
-1,098.45
-45.75%
Earnings per share (EPS)
1.30
-0.45
1.75
388.89%
Diluted Earnings per share
1.30
-0.45
1.75
388.89%
Operating Profit Margin (Excl OI)
15.99%
-8.73%
0.00
24.72%
Gross Profit Margin
19.10%
-3.27%
0.00
22.37%
PAT Margin
11.96%
-9.79%
0.00
21.75%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 76.17 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -2.82% vs 10.97% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 33.87% vs 28.82% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.11 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -10.33% vs 15.98% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 157.34% vs -31.26% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.43 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -12.78% vs 21.50% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 33.48% vs 52.71% in Mar 2025

Quarterly - Interest
Interest 1.47 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -25.00% vs 25.64% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 38.68% vs -64.90% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.99%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025